Both Mounjaro and Ozempic are generally well-tolerated, but like all medications, they can cause side effects, especially during the initial weeks of treatment as the body adjusts 7 , 8
[54] in women with PCOS, BMI 25 kg/m 2 and/or insulin resistance, treatment with liraglutide 1.8 mg/day for 26 weeks, along with a higher weight loss, induced significant reductions in fasting plasma glucose, HbA1c, and plasma glucose AUC, whereas Homeostatic Model Assessment for Insulin Resistance (HOMA-IR), Matsuda index and insulin AUC remained unchanged
It is crucial that any chest symptoms are properly evaluated, particularly in patients with cardiovascular risk factors
GHRH(1-29) analog for physiological growth hormone stimulation research CJC-1295 (No-DAC) + Ipamorelin: the synergy stack CJC-1295 is GHRH(1-29) with four stabilizing amino acid substitutions (among them D-Ala at position 2, which blocks DPP-IV degradation) [PMID 7962295]